Jian Ning

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 29, 2024

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Journal: Nature communications
Published: March 07, 2024

Identification of genes that promote PI3K pathway activation and prostate tumour formation.

Identification of genes that promote PI3K pathway activation and prostate tumour formation.

Journal: Oncogene
Published: September 15, 2023

Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer.

Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer.

Journal: Molecular cancer therapeutics
Published: June 08, 2023

Cell-type-specific tumour sensitivity identified with a bromodomain targeting PROTAC in adenoid cystic carcinoma.

Cell-type-specific tumour sensitivity identified with a bromodomain targeting PROTAC in adenoid cystic carcinoma.

Journal: The Journal of pathology
Published: April 21, 2023

Characterisation of a Novel Cell Line (ICR-SS-1) Established from a Patient-Derived Xenograft of Synovial Sarcoma.

Characterisation of a Novel Cell Line (ICR-SS-1) Established from a Patient-Derived Xenograft of Synovial Sarcoma.

Journal: Cells
Published: April 14, 2022

HER3 Is an Actionable Target in Advanced Prostate Cancer.

HER3 Is an Actionable Target in Advanced Prostate Cancer.

Journal: Cancer research
Published: October 04, 2021

Evolutionary selection of alleles in the melanophilin gene that impacts on prostate organ function and cancer risk.

Evolutionary selection of alleles in the melanophilin gene that impacts on prostate organ function and cancer risk.

Journal: Evolution, medicine, and public health
Published: March 09, 2021

Targeting the p300/CBP Axis in Lethal Prostate Cancer.

Targeting the p300/CBP Axis in Lethal Prostate Cancer.

Journal: Cancer discovery
Published: May 27, 2020

Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors.

Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors.

Journal: European urology
Published: May 22, 2020

A mouse SWATH-mass spectrometry reference spectral library enables deconvolution of species-specific proteomic alterations in human tumour xenografts.

A mouse SWATH-mass spectrometry reference spectral library enables deconvolution of species-specific proteomic alterations in human tumour xenografts.

Journal: Disease models & mechanisms
Published: February 22, 2020

Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer.

Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer.

Journal: Oncogene
Published: May 03, 2018
Showing 1-12 of 15

Last Updated: 09/26/2026